Observational Study to Evaluate Fertility in Women Between 32 and 38 Years Old Treated With the Ovosicare® Fertility

Last updated: July 17, 2025
Sponsor: Procare Health Iberia S.L.
Overall Status: Active - Recruiting

Phase

N/A

Condition

Reproductive Health

Treatment

N/A

Clinical Study ID

NCT07083999
FERTILOBS
  • Ages 32-38
  • Female

Study Summary

The goal of this observational study is to evaluate whether supplementation with the Ovosicare® Fertility food supplement increases the possibility of becoming pregnant in women aged between 32 and 38 years who have been trying to become pregnant for at least 6 months before starting supplementation.

Eligibility Criteria

Inclusion

Inclusion Criteria:

1.

  • Women who agree to participate in the study by signing the informed consent.

2.

  • Between 32 and 38 years old.

3.

  • Who come to doctor´s office stating that they have been trying to get pregnantfor at least 6 months.

Exclusion

Exclusion Criteria:

1.

  • BMI > 30 kg/m2.

2.

  • Existence of severe male factor subfertility according to the criteria of theWorld Health Organization (WHO), with at least one analysis obtained in thelast 6 months with one or more variables with values of:

  • Azoospermia

  • Progressive motility <25%

  • Normal morphology ≤2%

3.

  • Pregnant or breastfeeding women.

4.

  • Patients with type 1 diabetes or thyroid disease.

5.

  • Patients with any assisted reproduction technique scheduled during the durationof the study.

6.

  • Patients who have used or taken systemic steroids, anticonvulsants,antiretroviral treatment for HIV or hepatitis B in the last month.

7.

  • Patients with a known allergy to any of the components of Ovosicare® Fertility.

8.

  • Any other situation that, in the medical opinion, advises against treatmentwith Ovosicare® Fertility or that may make patient follow-up difficult.

9.

  • Patients with suspected endometriosis.

10.

  • Existence of fibroids affecting the endometrial cavity.

11.

  • Patients with 2 or more previous abortions.

12.

  • Patients with a current diagnosis of a high-risk human papillomavirus (HPV)cervical lesion.

Study Design

Total Participants: 300
Study Start date:
February 13, 2025
Estimated Completion Date:
December 31, 2026

Study Description

The duration of participation in the study for each patient will be a maximum of 18 months. This follow-up period may be shorter if a pregnancy occurs.

The number of visits throughout the study will be a total of three. Please note that you will not have to undergo additional tests or attend any extraordinary visits due to participating in this study, since the procedures you will undergo are the same as those routinely carried out in clinical practice.

Connect with a study center

  • CM Sitges

    Sitges, Barcelona
    Spain

    Active - Recruiting

  • HU de Getafe

    Getafe, Madrid
    Spain

    Active - Recruiting

  • Clínica Rv Benalmádena

    Benalmadena, Malaga
    Spain

    Active - Recruiting

  • H García Orcoyen

    Estella, Navarra
    Spain

    Active - Recruiting

  • CP Dr. Andrade Andrade

    A Coruña,
    Spain

    Active - Recruiting

  • CP Dra. Domenech Casanova

    Alicante,
    Spain

    Active - Recruiting

  • H Vega Baja de Orihuela

    Alicante,
    Spain

    Active - Recruiting

  • CP Dr. Aragón Albillos

    Almeria,
    Spain

    Active - Recruiting

  • Clinica Alboran

    Almeria,
    Spain

    Active - Recruiting

  • CM Teknon

    Barcelona,
    Spain

    Active - Recruiting

  • CP Dra. Mallafre

    Barcelona,
    Spain

    Site Not Available

  • HU Vall d'Hebron

    Barcelona,
    Spain

    Active - Recruiting

  • OBS Ginecólogos Burgos

    Burgos,
    Spain

    Active - Recruiting

  • Clínica Attella

    Castelló, 12004
    Spain

    Active - Recruiting

  • HU de Donostia

    Donostia, 20014
    Spain

    Site Not Available

  • CP Dra. Skouri-Bnihech Tioua

    Granada,
    Spain

    Active - Recruiting

  • CHU Insular - H Materno-Infantil

    Las Palmas,
    Spain

    Active - Recruiting

  • Clínica Palacios

    Madrid,
    Spain

    Active - Recruiting

  • Gymeiaka Dra. Oltra Badui

    Madrid,
    Spain

    Active - Recruiting

  • Gymeiaka Dra. Pavón Sanz

    Madrid,
    Spain

    Active - Recruiting

  • HU La Paz

    Madrid,
    Spain

    Active - Recruiting

  • Clínica Imar

    Murcia,
    Spain

    Active - Recruiting

  • Ancla Clínica Ginecológica

    Pontevedra,
    Spain

    Active - Recruiting

  • HG de la Santísima Trinidad

    Salamanca,
    Spain

    Active - Recruiting

  • CP Dra. Sánchez Quintana

    Sevilla,
    Spain

    Active - Recruiting

  • HU i Politècnic la Fe

    Valencia,
    Spain

    Active - Recruiting

  • Centro Ginecológico Bolonia

    Zaragoza,
    Spain

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.